Key Players
Major players operating in the Latin America smart insulin pen market are Medtronic Plc, Sanofi S.A., Novo Nordisk A/S, Eli Lilly and Company, Owen Mumford Ltd., BIOCORP, Jiangsu Delfu medical device Co., Ltd., BERLIN-CHEMIE AG, and F. Hoffmann-La Roche AG
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients